Navigation Links
Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
Date:4/25/2013

BALA CYNWYD, Pa., April 25, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of PROLOR Biotech, Inc. ("PROLOR" or the "Company") (NYSE- PBTH) relating to the proposed acquisition by OPKO Health, Inc. ("OPKO").

Under the terms of the transaction, PROLOR shareholders will receive only 0.9951 shares of OPKO stock for each share of PROLOR stock they own. The transaction values PROLOR stock at approximately $7.025 per share. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of PROLOR for not acting in the Company's shareholders' best interests in connection with the sale process. The transaction may undervalue the Company as an analyst has set a $12.00 per share price target on PROLOR stock. In addition, it has been reported that Deerpath Capital has indicated that the Company is worth more than $10.00 per share.

If you own shares of PROLOR stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com visiting http://brodsky-smith.com/571-pbth-prolor-biotech-inc.html, by calling toll free 877-LEGAL-90.

Attorney advertising. Prior results do not guarantee a similar outcome.


'/>"/>
SOURCE Brodsky & Smith, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
5. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
6. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
7. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
8. Codexis Names Wes Bolsen VP and Chief Marketing Officer
9. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
10. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
11. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)... BELLINGHAM, Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... for optics and photonics, has announced an agreement establishing Kinokuniya Company Ltd. as ... relationship with SPIE as the exclusive sales representative for the SPIE Digital Library ...
(Date:8/10/2017)... ... August 10, 2017 , ... ... AptaFluor SAH Methyltransferase Assay , an enabling new high throughput screening (HTS) ... that drive cancer and other debilitating diseases. , Chemical modification of gene expression, ...
(Date:8/8/2017)... , ... August 08, 2017 , ... ... growth factors expressed in human cells, today announced the launch of HumanKine® ... of the type I family of interferons that activate Th1-type innate immune responses against ...
(Date:8/8/2017)... ... August 08, 2017 , ... ... cancer research and personalized medicine, today announced the launch of its second generation ... company’s first generation PD-L1 test, enabling highly sensitive and specific profiling and monitoring ...
Breaking Biology Technology:
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):